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Abstract
Background: Undifferentiated embryonal sarcoma (UES) of liver is a rare malignant neoplasm,
which affects mostly the pediatric population accounting for 13% of pediatric hepatic malignancies,
a few cases has been reported in adults.
Case presentation: We report a case of undifferentiated embryonal sarcoma of the liver in a 20-
year-old Caucasian male. The patient was referred to us for further investigation after a laparotomy
in a district hospital for spontaneous abdominal hemorrhage, which was due to a liver mass. After
a through evaluation with computed tomography scan and magnetic resonance imaging of the liver
and taking into consideration the previous history of the patient, it was decided to surgically
explore the patient. Resection of I–IV and VIII hepatic lobe. Patient developed disseminated
intravascular coagulation one day after the surgery and died the next day.
Conclusion:  It is a rare, highly malignant hepatic neoplasm, affecting almost exclusively the
pediatric population. The prognosis is poor but recent evidence has shown that long-term survival
is possible after complete surgical resection with or without postoperative chemotherapy.
Background
Stocker et al, named undifferentiated embryonal sarcoma
of the liver, as an entity in 1978 on the basis of an Armed
Forces Institute of Pathology (AFIP) series [1]. It is a rare,
highly malignant hepatic neoplasm, affecting almost
exclusively the pediatric population. The prognosis is
poor but recent evidence has shown that long-term sur-
vival is possible after complete surgical resection with or
without postoperative chemotherapy. We report our expe-
rience treating a 20-year-old Caucasian male with undif-
ferentiated embryonal sarcoma of the liver.
Case presentation
A 20-years-old Caucasian male, presented to a district hos-
pital with acute right lower quadrant pain from six hours
before. Physical examination revealed abdominal pain,
localized right lower quadrant abdominal tenderness,
body temperature slightly elevated (37.7°C), blood pres-
sure 120/90 mmHg and heart rate 110/min. Blood tests
showed leukocyte count at 12600/µL, the differential
white account showing 75% neutrophils and hematocrit
35.9%. Abdominal and chest radiographs were normal.
The primary diagnosis was acute appendicitis and appen-
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dectomy was decided. Entering the peritoneal cavity from
a McBurney incision, the surgeon found large amount of
blood and the surgery was transformed to exploratory
laparotomy through a midline incision. The findings were
enormous hepatomegaly and bleeding due to spontane-
ous rupture of the IV lobe of the liver. Active bleeding was
managed with direct suture of identifiable vessels and
absorbable gauze mesh. Postoperative course was une-
ventful, except of a continuous elevated body temperature
(up to 38.5°C). The patient, five days after surgery, was
referred to us in order to undergo further examinations for
the nature of the liver abnormality. His medical history
was unremarkable. He was previously in good health. His
family and past history were not contributory. The patient
weighted 65 Kg with 1.75 m height. He was in his right
senses and well nourished. Yellow skin, icteric sclera, spi-
der naevi and palmar erythema were not founded. Cardi-
opulmonary examination was unremarkable. Chest
radiograph revealed no pulmonary pathology. The abdo-
men was swollen with the liver palpable. Laboratory tests
showed liver function tests normal (before the initial sur-
gery however, after the surgery SGOT, SGPT, LDH were
altered three times the normal range) hepatitis markers of
HAV, HBV, HCV, and HIV were negative and alpha-feto-
protein (AFP) was 35 ng/ml. The patient underwent com-
puted tomography (CT) of the abdomen that showed
hepatomegaly and a large hypodense lesion of the liver
with multicystic appearance with septations and solid
portions (Figure 1). Magnetic Resonance Imaging (MRI)
in T2-weighted and Short Time Inversion Recovery (STIR)
sequences revealing hyperdense areas with intermixed
hypodense septa (Figure 2), and a thrombus in the infe-
rior vena cava (Figure 3). The differential diagnosis by the
CT and MRI findings was giant hemangioma or cystic
malignant lesion. Due to the size of the lesion and the pre-
vious history of spontaneous bleeding, it was decided that
the patient must undergo surgery. In order to prevent pul-
monary embolism, an inferior vena cava filter was
inserted and fixated just below the renal veins. Two days
later the patient underwent surgery. Primarily, thrombec-
tomy and reconstruction of the inferior vena cava with
removal of the filter was performed, followed by hepatec-
tomy of I–IV and VIII lobe of the liver. Intraoperative
biopsy demonstrated malignancy or sarcoma of the liver.
Frozen section on the remaining liver was performed and
showed normal liver tissue. The patient after surgery pre-
sented with life threatening bleeding and protean coagu-
lation abnormalities, symptoms of disseminated
intravascular coagulation, due to massive blood transfu-
sion. The patient died the second postoperative day due to
uncontrolled bleeding caused of the developing of dis-
seminated intravascular coagulation (DIC). Pathologic
review of the specimen revealed a 1580 gm left and part of
right hepatic lobe, with a 30 × 14 × 9 cm tumor mass and
the histological examination showed malignant sarcoma-
tous tissue with spares giant neoplastic cells (head arrow)
and residual hepatocytes (arrow) suggestive of undifferen-
tiated embryonal sarcoma (Figure 4). Sarcomatous tissue
with severe atypia of the neoplastic cells and focal pres-
ence of giant cells partially with myoblastic characteristics
was also present (Figure 5). Residual hepatocytes stained
positive in immunohistochemical stain for cytoceratinin
8–18, and showed infiltration by the sarcomatous tissue
(DAB technique).
Magnetic Resonance Imaging (MRI) in T2-weighted and Short  Time Inversion Recovery (STIR) sequences revealing hyper- dense areas with intermixed hypodense septa Figure 2
Magnetic Resonance Imaging (MRI) in T2-weighted and Short 
Time Inversion Recovery (STIR) sequences revealing hyper-
dense areas with intermixed hypodense septa.
Computed tomography (CT) of the abdomen demonstrating  hepatomegaly and a large hypodense lesion of the liver with  multicystic appearance with septations and solid portions Figure 1
Computed tomography (CT) of the abdomen demonstrating 
hepatomegaly and a large hypodense lesion of the liver with 
multicystic appearance with septations and solid portions.World Journal of Surgical Oncology 2006, 4:9 http://www.wjso.com/content/4/1/9
Page 3 of 5
(page number not for citation purposes)
Discussion
Undifferentiated embryonal sarcoma (UES) of the liver
was first described as a clinicopathologic entity in 1978.
Before that, the nomenclature was variable and included
mesenchymoma, primary sarcoma of the liver, fibro-
myxosarcoma and malignant mesenchymoma [2].
After neuroblastoma and Wilm's tumor, primary hepatic
neoplasms are the third most common solid malignant
tumors found in children accounting for 2% of the total
of childhood cancers. Although rare, malignant mesen-
chymal hepatic tumors are the fourth most common
malignant tumors of the liver in the children, with hepa-
toblastoma and hepatocellular carcinoma accounting for
the majority of primary hepatic malignancies in children
[2,3].
The UES of the liver is typically diagnosed after 6 years of
age with a decline in incidence after 10 years of age and
50% of the patients were between the above ages in the
longest reported series [4]. In children, there is a slight
male predominance (1.0:0.65) [2]. In 1978, 31 patients
were reported with embryonal sarcoma with a median
survival time of less than 1 year [1]. A recent review of
published cases revealed a better outlook with 37.5% of
patients alive without disease for an average of 37.5
months [5]. Two further patients are reported alive and
free of disease more than 5 years after complete surgical
excision of tumor and chemotherapy [5].
The UES of the liver is a rare tumor that most often
presents in childhood but infrequently in adults. Less
than 60 cases of UESL in adults have been reported in the
pertinent literature [2,6-9].
There are no specific clinical features. Tumor related
symptoms might be regarded as abdominal mass with or
without upper abdominal pain or swelling. Fever is prob-
ably related to the hemorrhage and necrosis found in the
majority of these tumors, as happened in our patient. Of
possible significance is the absence of jaundice. Rupture
into the tumor or into the peritoneal cavity due to rapid
growth of the tumor is not uncommon [10]. Review of the
literature did not reveal a case of undifferentiated embry-
onal sarcoma mimicking acute appendicitis. Different
from primary carcinoma of the liver, UESL has no relation
to hepatitis or liver cirrhosis, no disturbance of hepatic
function. Laboratory studies are non-specific, and the α-
fetoprotein is not increased [1,2,7].
Radiographs of the abdomen are usually normal. The
lesion can be detected by ultrasound, CT and MRI. MRI
localizes the lesion more accurately than the other meth-
ods, with good resectability correlation. It also can detect
vascular invasion, biliary obstruction and hilar adenopa-
thies [11].
UES of the liver is a neoplasm with primitive mesenchy-
mal phenotype. Tumor size often exceeds 10 cm and can
be as large as 30 cm. Macroscopic examination shows a
single, well-demarcated, soft, globular mass that fre-
quently has cystic, gelatinous, hemorrhagic and necrotic
foci. Microscopic examination reveals a pseudocapsule
surrounding a neoplasm, composed predominately of
spindle, oval, or stellate cells with ill-defined cell borders.
The tumor cells are embedded in an abundant myxoid
stroma that contains many thin-walled veins. The bile
MRI revealing a thrombus in the inferior vena cava (the  arrow shows the thrombus)] Figure 3
MRI revealing a thrombus in the inferior vena cava (the 
arrow shows the thrombus)].
Microphotograph of malignant sarcomatous tissue with  spares giant neoplastic cells (head arrow) and residual hepa- tocytes (arrow) (H-E stain, × 100) Figure 4
Microphotograph of malignant sarcomatous tissue with 
spares giant neoplastic cells (head arrow) and residual hepa-
tocytes (arrow) (H-E stain, × 100).World Journal of Surgical Oncology 2006, 4:9 http://www.wjso.com/content/4/1/9
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duct-like structures occasionally appear hyperplastic or
reactive, although they, too, may show degenerative
changes [1]. Immunohistochemical studies have indi-
cated variable immunoreactivity with antibodies to
desmin, muscle-specific actin, and cytokeratin, but not
myoglobin [3]. Vimentin and the "histiocytic" determi-
nants (alpha-1-antitrypsin and alpha-1-antichymot-
rypsin) have been the only consistent
immunohistochemical markers expressed by this tumor.
However, it is known that the latter two markers are not
specific for histiocytes, but are expressed in a range of tis-
sue types including epithelium [4]. In our case the immu-
nohistochemical studies revealed expression to vimentin,
desmin, but not to muscle-specific actin, S-100-protein
and cytokeratin.
Evaluable treatments included surgery, hepatic arterial
ligation, hepatic transplantation, and combinations of
surgery and/or chemotherapy and radiation therapy. Rad-
ical resection of the tumor is the optimal treatment of
choice [12,13]. According to McFadden et al, combination
chemotherapy and radiation therapy, followed by elective
resection, should be considered for all adult patients with
UES. Similar protocols are reasonable for pediatric
patients too [2,14].
The prognosis for UESL has been poor to until recently
and majority of the patients died of tumor recurrence or
metastasis within two years after the initial operation [1].
The major impediments in achieving long-term, disease-
free intervals, is local recurrence in the upper abdomen
and distant metastases [4]. Metastases to lung, pleura and
peritoneum are common; invasion of the vena cava with
extension into the right atrium rarely occurs [3]. Recent
researchers have shown that pre- and/or post-operative
systemic chemotherapy (with cisplatin, andriamycin,
cyclophosphamide) and/or radiotherapy, when neces-
sary, can remarkably improve patient's survival [15,16].
Because the tumor does not produce any characteristic
serum markers to permit monitoring of subclinical recur-
rences, the second-look laparotomy after the completion
of chemotherapy should be considered [4]. Once there is
an evidence of recurrence, resection of the tumor wherever
feasible should be performed [7].
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